InvestorsHub Logo

ombowstring

08/27/20 10:57 AM

#111659 RE: gimmeshelter #111647

Yes, maybe a libel suit should be filed in a court of law. I would think an entity like the Wall Street Journal would issue a retraction and soon.

Black-Ops

08/27/20 11:11 AM

#111671 RE: gimmeshelter #111647

On the Wall Street Journal (WSJ). To those that were actually instructed to interpret the meaning and purpose of what was written; Wursthorn is not a reporter but an editorialist. He disguises opinion as news.

Is this Wursthorn's second hit piece on CYDY? This IS the second hit job by the WSJ

If Wursthorn's BARDA statement as fact is in fact false then CYDY has a slam dunk libel case.

Why would Wursthorn do such? Person relationship with shorts or is a short. Respect for the dude known as Adal F. of STAT.

Ad buys in the Wall Street Journal by Big Pharma.

Consider this; Big Pharma approaches someone in the Wall Street Journal sales office. We will buy 2 or 5 million in full page ads if you write 10 hit pieces against CYDY. I have written extensively why Big Pharma will and continue to attack CYDY. It is at least 500 million $$$ per week in revenues the Big Pharma will loose and CYDY will gain. It is also untold suffering by the sick that will disappear because of our, CYDY Leronlimab.

If anyone does not think this possible they just made it out of a worthless University. Welcome to the real world Wall Street Journal believers. It is not what it was 50 years ago.

It is now another print and online joke. All my opinion of course.